Significant R&D activities in the pharmaceutical sector propel the US life science instrumentation market

The US life science instrumentation market is projected to grow at a significant CAGR of around 6.2% during the forecast period (2021-2027). The US is anticipated to be a major contributor to the growth of the life science instrumentation market. Significant funding for life science-related research in the country is a key factor contributing to the growth of the US life science instrumentation market. DNA sequencing technologies have emerged as efficient technology in the US as an alternative to treat numerous chronic diseases across the country. However, scientists consider the microbiome as the second genome and some even term it as one of the human body organs. Therefore, the increasing demand for these sequencing technologies further expand the adoption of life science instrumentation in the country.

Browse the full report description of "US Life Science Instrumentation Market Size, Share & Trends Analysis Report by Technology (Chromatography, Spectroscopy, Polymerase Chain Reaction (PCR), Clinical Chemistry Analyzers, Immunoassays, Next Generation Sequencing (NGS), Flow Cytometry, Microscopy, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Hospitals & Laboratories) and Forecast 2021-2027" at  https://www.omrglobal.com/industry-reports/us-life-science-instrumentation-market

Moreover, growing cell culture research in the country further provides a significant opportunity to the life science instrumentation market in the region. The US is expected to register a significant share in the cell culture market due to the presence of major life science companies and increased R&D projects in cancer research. Cell culture is widely being used in the US biopharmaceutical industries for vaccine production, drug development, tissue culture, and engineering and the production of monoclonal antibodies and therapeutics for cancer. The US biopharmaceutical sector provides important R&D investments supporting new treatments and potential cures that improve the health and well?being of individuals. The biopharmaceutical sector sustains a large?scale supply chain—both in R&D and in support of the production and distribution of life science instrumentation products in the country.

Market Coverage

Key questions addressed by the report

• What is the market growth rate during the forecast period?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market during the forecast period?
• How will COVID-19 impact the market growth in 2020 and the coming years?

o Recovery Timeline

o Deviation from the pre-COVID forecast

o Most affected segment

o Recommendations 

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

US Life Science Instrumentation Market – Segmentation

By Technology

• Chromatography
• Spectroscopy
• Polymerase Chain Reaction (PCR)
• Clinical Chemistry Analyzers
• Immunoassays
• Next-Generation Sequencing (NGS)
• Flow Cytometry
• Microscopy 
• Others (Centrifuges, Electrophoresis)

By End-User

• Pharmaceutical & Biotechnology Companies
• Research Institutes 
• Hospitals and Laboratories 

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/us-life-science-instrumentation-market